Literature DB >> 8370173

Functional analysis of TCR gamma delta+ T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer.

J Kitayama1, Y Atomi, H Nagawa, A Kuroda, T Mutoh, M Minami, T Juji.   

Abstract

In six patients with advanced pancreatic carcinoma, TIL and tumour-draining lymphocytes (TDL) were isolated from primary pancreatic tumour and regional lymph nodes. In comparison with TDL and peripheral blood lymphocytes (PBL), TIL contained a comparatively higher percentage of TCR gamma delta+ cells, although they were still a small fraction. By 2 weeks culture with rIL-2 and immobilized OKT-3 antibody, the TCR gamma delta+ cells in TIL were preferentially expanded at the early culture periods, although it was temporary. In four cases, the TCR gamma delta+ and CD8+ TCR alpha beta+ TIL were separated by negative sorting using flowcytometry. All the TCR gamma delta+ TIL were CD4-, CD8- (double negative), and one of the TIL lines was mostly composed of delta TCS1+ cells, while the others were delta TCS1-. In comparison with CD8+ TCR alpha beta+ TIL, all the TCR gamma delta+ TIL exhibited much stronger lytic activity against freshly isolated autologous pancreatic cancer cells. However, all the gamma delta+ TIL also exhibited a strong non-MHC-restricted cytotoxicity, and there was no correlation between the lytic pattern and the percentage of delta TCS1+ cells. These data suggest that the TCR gamma delta+ T cells can proliferate vigorously in a certain condition, and if successfully expanded in vitro they might be helpful material for effective adoptive immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370173      PMCID: PMC1554920          DOI: 10.1111/j.1365-2249.1993.tb08198.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Subpopulations of human peripheral T gamma delta lymphocytes.

Authors:  F Triebel; T Hercend
Journal:  Immunol Today       Date:  1989-06

2.  Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid.

Authors:  J Holoshitz; F Koning; J E Coligan; J De Bruyn; S Strober
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells.

Authors:  O Janssen; S Wesselborg; B Heckl-Ostreicher; K Pechhold; A Bender; S Schondelmaier; G Moldenhauer; D Kabelitz
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

4.  Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex.

Authors:  D D Schoof; C M Selleck; A F Massaro; S E Jung; T J Eberlein
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

5.  Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans.

Authors:  R P Bucy; C L Chen; M D Cooper
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

6.  Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Authors:  S A Rosenberg; M T Lotze; J C Yang; P M Aebersold; W M Linehan; C A Seipp; D E White
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

7.  Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.

Authors:  C M Balch; L B Riley; Y J Bae; M A Salmeron; C D Platsoucas; A von Eschenbach; K Itoh
Journal:  Arch Surg       Date:  1990-02

8.  Human gamma delta+ T cells respond to mycobacterial heat-shock protein.

Authors:  A Haregewoin; G Soman; R C Hom; R W Finberg
Journal:  Nature       Date:  1989-07-27       Impact factor: 49.962

9.  Identification of activated T cell receptor gamma delta lymphocytes in the liver of tumor-bearing hosts.

Authors:  S Seki; T Abo; T Masuda; T Ohteki; A Kanno; K Takeda; H Rikiishi; H Nagura; K Kumagai
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

10.  Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.

Authors:  Y K Yoo; D S Heo; K Hata; D H Van Thiel; T L Whiteside
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

View more
  15 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

2.  Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging.

Authors:  K Ademmer; M Ebert; F Müller-Ostermeyer; H Friess; M W Büchler; W Schubert; P Malfertheiner
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Audrey Benyamine; Céline Loncle; Etienne Foucher; Juan-Luis Blazquez; Céline Castanier; Anne-Sophie Chrétien; Mauro Modesti; Véronique Secq; Salem Chouaib; Meritxell Gironella; Elena Vila-Navarro; Giuseppe Montalto; Jean-Charles Dagorn; Nelson Dusetti; Juan Iovanna; Daniel Olive
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

Review 4.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

5.  Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes.

Authors:  N Watanabe; A Hizuta; N Tanaka; K Orita
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 6.  Immunotherapy for gastrointestinal malignancies.

Authors:  Paul G Toomey; Nasreen A Vohra; Tomar Ghansah; Amod A Sarnaik; Shari A Pilon-Thomas
Journal:  Cancer Control       Date:  2013-01       Impact factor: 3.302

7.  Suppression of cytotoxic T lymphocyte activity by gamma/delta T cells in tumor-bearing mice.

Authors:  N Seo; K Egawa
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

8.  Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

Authors:  M J Maeurer; D Martin; W Walter; K Liu; L Zitvogel; K Halusczcak; H Rabinowich; R Duquesnoy; W Storkus; M T Lotze
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 9.  Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.

Authors:  Elena Lo Presti; Franceso Dieli; Serena Meraviglia
Journal:  Front Immunol       Date:  2014-11-24       Impact factor: 7.561

Review 10.  Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors.

Authors:  Sihan Chen; Zhangyun Li; Wenyi Huang; Yanyan Wang; Shaohua Fan
Journal:  J Cancer       Date:  2021-05-27       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.